Analysis of circulating tumour DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients

被引：0
|
作者：
Grech, C. [1 ]
Hackner, K. [2 ]
Strieder, M. [2 ]
Buder, A. [1 ]
Hochmair, M. J. [3 ,4 ]
Filipits, M. [1 ]
Errhalt, P. [2 ]
机构：
[1] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Inst Canc Res, Vienna, Austria
[2] Karl Landsteiner Univ Hlth Sci, Univ Hosp Krems, Dept Pneumol, Krems, Austria
[3] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria
[4] Otto Wagner Hosp, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1417P
引用
收藏
页码：578 / 578
页数：1
相关论文
共 50 条
  • [31] Prognostic impact of bone metastases in osimertinib-treated patients with EGFR-mutated NSCLC
    Tanaka, Ichidai
    Gen, Soei
    Hori, Kazumi
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Ishii, Makoto
    CANCER SCIENCE, 2025, 116 : 329 - 329
  • [32] Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC
    Barr, Martin P.
    Baird, Anne-Marie
    Halliday, Sophia
    Martin, Petra
    Allott, Emma H.
    Phelan, James
    Korpanty, Greg
    Coate, Linda
    O'Brien, Cathal
    Gray, Steven G.
    Sui, Jane S. Y.
    Hayes, Brian
    Cuffe, Sinead
    Finn, Stephen P.
    DIAGNOSTICS, 2022, 12 (10)
  • [33] Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis
    Yi, Lilan
    Fan, Junsheng
    Qian, Ruolan
    Luo, Peng
    Zhang, Jian
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (01) : 284 - 294
  • [34] Clinical Validation of Plasma Cell Free DNA Mutation Detection in Patients with EGFR-Mutated Lung Cancer
    Sholl, L. M.
    Bruce, J. L.
    Alden, R. S.
    Lydon, C. A.
    Feeney, N. B.
    Paweletz, C. P.
    Oxnard, G. R.
    Lindeman, N. I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1026 - 1027
  • [35] Early TKI-pharmokinetics and circulating tumor DNA (ctDNA) to predict outcome in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Bigot, Frederic
    Pecuchet, Nicolas
    Blanchet, Benoit
    Laurent-Puig, Pierre
    Blons, Helene
    Goldwasser, Francois
    Boudou-Rouquette, Pascaline
    Auclin, Edouard
    Oudard, Stephane
    Fabre, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Longitudinal circulating-tumor DNA profiling of EGFR-mutated lung adenocarcinoma patients treated with EGFR-tyrosine kinase inhibitors
    Ortiz-Cuaran, S.
    Swalduz, A.
    Leonce, C.
    Martinez, S.
    Clapisson, G.
    Marteau, S.
    Avrillon, V.
    Green, E.
    Morris, C.
    Perol, M.
    Saintigny, P.
    ANNALS OF ONCOLOGY, 2017, 28 : 1 - 1
  • [37] Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
    Ebert, Eva Boysen Fynboe
    McCulloch, Tine
    Hansen, Karin Holmskov
    Linnet, Hanne
    Sorensen, Boe
    Meldgaard, Peter
    LUNG CANCER, 2020, 143 : 67 - 72
  • [38] Concordances assessment between MET-positive circulating tumour cells and disease progression in patients with EGFR mutated NSCLC
    Park, J.
    Kim, N. Y.
    Kim, J.
    Oh, E.
    Nam, J-H.
    Kim, H. Y.
    Kim, H-E.
    Choi, H.
    Choi, J.
    Shin, Y. K.
    Lee, S-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S811 - S811
  • [39] Depth of Response to First-Line EGFR TKI Does Not Predict Survival in EGFR-Mutated NSCLC Patients
    Wu, Ting-Hui
    Hsiue, Emily
    Lee, Jih-Hsiang
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S386 - S387
  • [40] Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma
    Park, Sehhoon
    Shim, Joon Ho
    Lee, Boram
    Cho, Inju
    Park, Woong-Yang
    Kim, Youjin
    Lee, Se-Hoon
    Choi, Yoon La
    Han, Joungho
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    LUNG CANCER, 2019, 134 : 7 - 15
12345